SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-19-122482
Filing Date
2019-04-26
Accepted
2019-04-26 16:34:32
Documents
3
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d738534d10ka.htm 10-K/A 22050
2 EX-31.1 d738534dex311.htm EX-31.1 5901
3 EX-31.2 d738534dex312.htm EX-31.2 5935
  Complete submission text file 0001193125-19-122482.txt   35039
Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38096 | Film No.: 19772203
SIC: 2834 Pharmaceutical Preparations